Core Points - The chairman of Weining Health, Zhou Wei, has submitted his resignation due to personal reasons [1] - Liu Ning, one of the company's main founders, has been elected as the new chairman of the sixth board of directors [1] - The new chairman's term will last until the end of the current board's term [1]

人民财讯11月9日电，卫宁健康（300253）11月9日公告，董事长周炜因个人原因，申请辞去公司第六届 董事会董事长(董事)、董事会提名委员会委员、董事会审计委员会委员及董事会薪酬与考核委员会委 员、法定代表人职务。辞去上述职务后，周炜不再是公司董事、监事、高级管理人员，继续在公司担任 顾问，另外仍担任公司全资子公司卫宁互联网科技有限公司执行董事、上海卫宁软件有限公司执行董事 (待后续按流程再行变更)。公司于11月8日召开了第六届董事会第二十一次会议，同意选举公司主要创 始人之一的刘宁担任公司第六届董事会董事长，任期自本次董事会审议通过之日起至第六届董事会届满 之日。 ...

Core Viewpoint - The resignation of Chairman Zhou Wei from the board of Weining Health due to personal reasons, with subsequent leadership changes and board nominations [1] Group 1: Leadership Changes - Zhou Wei has submitted his resignation from the positions of Chairman, board member, and various committee roles, effective immediately [1] - Following Zhou Wei's resignation, Liu Ning, one of the company's main founders, has been elected as the new Chairman of the sixth board, with a term lasting until the board's term ends [1] - Zhou Cheng has been nominated as a candidate for a non-independent director on the sixth board, pending approval from the shareholders' meeting [1] Group 2: Company Structure - Zhou Wei will continue to serve as an advisor to the company and will remain as the executive director of the wholly-owned subsidiary, Weining Internet Technology Co., Ltd., and Shanghai Weining Software Co., Ltd., pending further procedural changes [1]

证券代码：300253 证券简称：卫宁健康 公告编号：2025-087 卫宁健康科技集团股份有限公司 第六届董事会第二十一次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完 整，没有虚假记载、误导性陈述或重大遗漏。 卫宁健康科技集团股份有限公司（以下简称"公司"）于 2025 年 11 月 8 日以通讯方式召开了第六届董事会第二十一次会议。会议 通知于 2025 年 11 月 8 日以专人送达及电子邮件方式发出。会议应出 席董事 6 人，实际出席董事 6 人。本次董事会的召集和召开符合《中 华人民共和国公司法》和《公司章程》的规定。会议由副董事长刘宁 先生主持，公司高级管理人员、非独立董事候选人周成先生列席了本 次董事会。经与会董事表决，形成决议如下： 一、会议以 6 票同意、0 票反对、0 票弃权的结果审议通过了《关 于董事会会议豁免通知时限的议案》 经审议，同意豁免公司第六届董事会第二十一次会议的通知期限， 并于 2025 年 11 月 8 日召开第六届董事会第二十一次会议。 二、会议以 6 票同意、0 票反对、0 票弃权的结果审议通过了《关 于选举公司第六届董事会董事长暨变更法定代表 ...

Core Viewpoint - The resignation of Chairman Zhou Wei from the board of Weining Health due to personal reasons, with subsequent leadership changes and board nominations [1] Group 1: Leadership Changes - Zhou Wei has submitted his resignation from the positions of Chairman, board member, and various committee roles, effective immediately [1] - Following Zhou Wei's resignation, Liu Ning, one of the company's main founders, has been elected as the new Chairman of the sixth board, with a term lasting until the board's term ends [1] - Zhou Cheng has been nominated as a non-independent director candidate for the sixth board, pending approval from the shareholders' meeting [1] Group 2: Company Structure - Zhou Wei will continue to serve as an advisor to the company and will remain as the executive director of the wholly-owned subsidiary Weining Internet Technology Co., Ltd. and Shanghai Weining Software Co., Ltd. [1] - The sixth board's twenty-first meeting was held on November 8, 2025, to discuss and approve the leadership changes [1]

Group 1 - The core point of the article is that Weining Health (SZ 300253) held its 21st meeting of the 6th board of directors on November 8, 2025, via telecommunication, where it reviewed the proposal for nominating non-independent director candidates [1] - For the first half of 2025, Weining Health's revenue composition was 92.54% from the healthcare information technology sector and 7.46% from the internet healthcare sector [1] - As of the report, Weining Health has a market capitalization of 18 billion yuan [1] Group 2 - The article also mentions that Nohui Health's headquarters in Hangzhou has multiple vacant office spaces, and its Beijing laboratory is facing rent payment issues [1] - A former employee indicated that the reported issues at Nohui Health are just the tip of the iceberg [1]

证券代码：300253 证券简称：卫宁健康 公告编号：2025-088 卫宁健康科技集团股份有限公司 关于董事长辞职及选举新董事长暨变更法定代表人、提名非 独立董事候选人的公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完 整，没有虚假记载、误导性陈述或重大遗漏。 一、关于董事长辞职事项 卫宁健康科技集团股份有限公司（以下简称"公司"）董事会于 近日收到董事长周炜先生的书面辞职报告，周炜先生因个人原因，申 请辞去公司第六届董事会董事长（董事）、董事会提名委员会委员、 董事会审计委员会委员及董事会薪酬与考核委员会委员、法定代表人 职务。辞去上述职务后，周炜先生不再是公司董事、监事、高级管理 人员，继续在公司担任顾问，另外仍担任公司全资子公司卫宁互联网 科技有限公司执行董事、上海卫宁软件有限公司执行董事（待后续按 流程再行变更）。 周炜先生原定本届任期为 2024 年 3 月 21 日至 2027 年 3 月 20 日。 根据《公司法》《深圳证券交易所上市公司自律监管指引第 2 号—— 创业板上市公司规范运作》及《公司章程》等有关规定，周炜先生的 辞职未导致公司董事会成员低于法定最低人数，不会影响公司董 ...

证券代码：300253 证券简称：卫宁健康 公告编号：2025-089 卫宁健康科技集团股份有限公司 关于召开 2025 年第二次临时股东会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 一、召开会议的基本情况 1、股东会届次：2025 年第二次临时股东会 2、股东会的召集人：董事会 3、本次会议的召集、召开符合《中华人民共和国公司法》《深 圳证券交易所创业板股票上市规则》《深圳证券交易所上市公司自 律监管指引第 2 号—创业板上市公司规范运作》等法律、行政法规、 部门规章、规范性文件及《公司章程》的有关规定。 4、会议时间： 5、会议的召开方式：现场表决与网络投票相结合。 6、会议的股权登记日：2025 年 11 月 18 日 7、出席对象： （1）在股权登记日持有公司股份的普通股股东（含表决权恢 复的优先股股东）或其代理人。于股权登记日 2025 年 11 月 18 日 下午收市时在中国证券登记结算有限责任公司深圳分公司登记在册 的公司全体普通股股东（含表决权恢复的优先股股东）均有权出席 股东会，并可以以书面形式委托代理人出席会议和参加表决，该股 ...

Core Viewpoint - Weining Health Technology Group Co., Ltd. and its actual controller, Chairman Zhou Wei, have been sentenced for bribery, with the company facing a fine and Zhou receiving a prison sentence [1][3]. Group 1: Legal Issues - Weining Health's subsidiary, Shenzhen Weining Zhongtian Software Co., Ltd., was found guilty of bribery and fined 800,000 yuan [1][3]. - Chairman Zhou Wei was sentenced to one and a half years in prison and fined 200,000 yuan for the same offense [1][3]. - Both the company and Zhou Wei plan to appeal the verdict [2][3]. Group 2: Financial Impact - The fine of 800,000 yuan represents 0.9% of the company's most recent audited net profit attributable to shareholders [3]. - Shenzhen Weining Zhongtian's revenue for 2022, 2023, and 2024 is projected at 23.68 million yuan, 15.64 million yuan, and 13.65 million yuan, respectively, accounting for 0.77%, 0.49%, and 0.49% of Weining Health's total revenue [3]. - The net profit for the same years is expected to be 9.99 million yuan, 11.27 million yuan, and 7.00 million yuan, representing 9.20%, 3.15%, and 7.97% of Weining Health's net profit [3]. Group 3: Management and Operations - Other board members and senior management are continuing their duties normally, with Vice Chairman Liu Ning set to assume the role of acting Chairman [4]. - The company has experienced a significant decline in revenue, with a 32.27% year-on-year drop in the first three quarters [5][8]. - Weining Health's overall revenue and profit have decreased due to various factors, including delayed project acceptance and cost pressures [7].

Core Viewpoint - The China Securities Medical Index (399989) closed at 7223.8 points, down 0.15%, with a trading volume of 16.39 billion yuan and a turnover rate of 1.58% on November 6 [1][3] Group 1: Index Performance - On the same day, 25 constituent stocks rose, with Furuide Co., Ltd. leading with a 4.32% increase, while 25 stocks fell, with Weining Health leading the decline at 10.38% [1] - The top ten constituent stocks of the China Securities Medical Index are primarily in the biopharmaceutical sector, with WuXi AppTec holding the highest weight at 13.85% and a market capitalization of 285.52 billion yuan [1] Group 2: Fund Flow - The net outflow of main funds from the constituent stocks totaled 823 million yuan, while retail investors saw a net inflow of 624 million yuan [3] - Specific stocks like Taige Pharmaceutical and Furuide Co., Ltd. experienced varying levels of net inflow and outflow from different investor categories, indicating diverse investor sentiment [3]